Compare Indoco Remedies with GREENPLY IND - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs GREENPLY INDUSTRIES - Comparison Results

INDOCO REMEDIES     Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES GREENPLY INDUSTRIES INDOCO REMEDIES/
GREENPLY INDUSTRIES
 
P/E (TTM) x 127.1 19.4 655.9% View Chart
P/BV x 2.1 2.0 104.5% View Chart
Dividend Yield % 0.6 0.4 158.3%  

Financials

 INDOCO REMEDIES   GREENPLY INDUSTRIES
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-18
GREENPLY INDUSTRIES
Mar-18
INDOCO REMEDIES/
GREENPLY INDUSTRIES
5-Yr Chart
Click to enlarge
High Rs317401 79.1%   
Low Rs178255 69.8%   
Sales per share (Unadj.) Rs113.1139.7 80.9%  
Earnings per share (Unadj.) Rs4.59.0 49.5%  
Cash flow per share (Unadj.) Rs11.813.1 90.3%  
Dividends per share (Unadj.) Rs1.000.60 166.7%  
Dividend yield (eoy) %0.40.2 220.7%  
Book value per share (Unadj.) Rs73.271.6 102.4%  
Shares outstanding (eoy) m92.15122.63 75.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.22.3 93.3%   
Avg P/E ratio x55.536.4 152.5%  
P/CF ratio (eoy) x21.025.1 83.6%  
Price / Book Value ratio x3.44.6 73.8%  
Dividend payout %22.46.7 336.6%   
Avg Mkt Cap Rs m22,83040,229 56.8%   
No. of employees `0005.53.7 149.2%   
Total wages/salary Rs m2,2091,967 112.3%   
Avg. sales/employee Rs Th1,910.14,687.3 40.7%   
Avg. wages/employee Rs Th405.0538.1 75.3%   
Avg. net profit/employee Rs Th75.5302.7 24.9%   
INCOME DATA
Net Sales Rs m10,41917,132 60.8%  
Other income Rs m4722 217.1%   
Total revenues Rs m10,46617,154 61.0%   
Gross profit Rs m1,3492,308 58.5%  
Depreciation Rs m677498 135.9%   
Interest Rs m235114 207.0%   
Profit before tax Rs m4841,717 28.2%   
Minority Interest Rs m0-76 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m72535 13.5%   
Profit after tax Rs m4121,106 37.2%  
Gross profit margin %12.913.5 96.1%  
Effective tax rate %15.031.2 48.0%   
Net profit margin %4.06.5 61.2%  
BALANCE SHEET DATA
Current assets Rs m5,3736,482 82.9%   
Current liabilities Rs m4,1576,157 67.5%   
Net working cap to sales %11.71.9 616.3%  
Current ratio x1.31.1 122.8%  
Inventory Days Days6849 137.5%  
Debtors Days Days7361 119.7%  
Net fixed assets Rs m6,24413,509 46.2%   
Share capital Rs m184123 150.3%   
"Free" reserves Rs m6,5668,652 75.9%   
Net worth Rs m6,7508,775 76.9%   
Long term debt Rs m1,2334,848 25.4%   
Total assets Rs m12,36321,111 58.6%  
Interest coverage x3.116.1 19.0%   
Debt to equity ratio x0.20.6 33.1%  
Sales to assets ratio x0.80.8 103.9%   
Return on assets %5.25.8 90.5%  
Return on equity %6.112.6 48.4%  
Return on capital %9.012.9 69.9%  
Exports to sales %01.8 0.0%   
Imports to sales %016.4 0.0%   
Exports (fob) Rs mNA309 0.0%   
Imports (cif) Rs mNA2,811 0.0%   
Fx inflow Rs m3,762309 1,219.5%   
Fx outflow Rs m1,1432,811 40.7%   
Net fx Rs m2,619-2,503 -104.6%   
CASH FLOW
From Operations Rs m1,2271,134 108.2%  
From Investments Rs m-1,360-3,280 41.5%  
From Financial Activity Rs m-3881,644 -23.6%  
Net Cashflow Rs m-521-502 103.8%  

Share Holding

Indian Promoters % 59.2 55.0 107.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 6.5 192.3%  
FIIs % 6.0 15.3 39.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 23.3 96.1%  
Shareholders   12,805 3,736 342.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   JSW HOLDINGS  COMMEX TECHNOLOGY  STC INDIA  COX & KINGS  GEOJIT FINANCIAL SERVICES  



Today's Market

Sensex Tanks 642 Points; Automobile and Realty Stocks Plunge(Closing)

Indian share markets fell sharply today amid fears of rising crude oil prices and weakness in the rupee rattled investor sentiment.

Related Views on News

GREENPLY INDUSTRIES Announces Quarterly Results (1QFY20); Net Profit Down 34.0% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, GREENPLY INDUSTRIES has posted a net profit of Rs 157 m (down 34.0% YoY). Sales on the other hand came in at Rs 3 bn (down 24.6% YoY). Read on for a complete analysis of GREENPLY INDUSTRIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

GREENPLY IND Announces Quarterly Results (3QFY19); Net Profit Down 1.0% (Quarterly Result Update)

Feb 11, 2019 | Updated on Feb 11, 2019

For the quarter ended December 2018, GREENPLY IND has posted a net profit of Rs 357 m (down 1.0% YoY). Sales on the other hand came in at Rs 5 bn (up 15.9% YoY). Read on for a complete analysis of GREENPLY IND's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Sep 17, 2019 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 8-QTR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS